Promising Anti-atherosclerotic Effect of Berberine: Evidence from In Vitro, In Vivo, and Clinical Studies
Reviews of physiology, biochemistry and pharmacology2020Vol. 178, pp. 83–110
Citations Over TimeTop 1% of 2020 papers
Alireza Fatahian, Saeed Mohammadian Haftcheshmeh, Sara Azhdari, Helaleh Kaboli Farshchi, Banafsheh Nikfar, Amir Abbas Momtazi‐Borojeni
Related Papers
- → Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation(2014)89 cited
- → Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells by Suppressing AP-1 Activity and Activation of the Nrf2/HO-1 Pathway(2019)80 cited
- → Berberine Contents as a Quality Marker in Medicinal Plants andAmounts of Berberine Passing into Serum(2023)1 cited
- Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage(2009)
- → Berberine through PPAR- γ/HO-1 Pathway Regulates Macrophage Polarization(2023)